Skip to content

Race, Ethnicity, Socioeconomic Status and Prolapse-rElated Decisional ConflicT

Race, Ethnicity, Socioeconomic Status and Prolapse-rElated Decisional ConflicT

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04977141
Acronym
RESPECT
Enrollment
210
Registered
2021-07-26
Start date
2021-07-07
Completion date
2024-05-01
Last updated
2025-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse, Prolapse, Urogenital

Keywords

decisional conflict, pelvic organ prolapse, decision making

Brief summary

This study is trying to see if people from different backgrounds have different feelings when making treatment decisions about prolapse.

Detailed description

This multi-center study will include patients ages \>18 years with prolapse symptoms who have new patient consultations to Female Pelvic Medicine and Reconstructive Surgery providers. After the new-patient consultation, patients will be contacted to see if they are interested in the study. If so, informed consent will be obtained before they complete a 1 page questionnaire that assesses their eligibility for participation. The questionnaires are: Decisional Conflict Scale; Pelvic Floor Disorders Autonomy Preference Index; Control Preferences Scale; Pelvic Floor Distress Inventory (PFDI 20); Satisfaction with Decision Scale for Pelvic Floor Disorders; Impression questionnaire. Patients will self-identify their zip-code on the patient impression questionnaire. This will enable a geographic analysis that will assess the relationships of neighborhood and commute on decision making. For the purposes of this study, patients will self-identify their demographic information. URM patients will be those who self-identify as having a non-Caucasian race and/or a Hispanic ethnicity. Providers seeing patients that are included in this study will also be consented prior to completing a 1 time demographics questionnaire. Additional clinical data will also be obtained. Patients will be able to utilize interpreters to participate. Information regarding the use of interpreters will be collected. Questionnaires that are available in, and validated in, non-English languages will be used as appropriate. The lead study site is Women & Infants Hospital/ Brown University, with additional study sites planning to participate in the study.

Interventions

OTHERDecisional Conflict Scale

Decisional Conflict Scale

Sponsors

Fellows Pelvic Research Network (sponsor)
CollaboratorUNKNOWN
Northwestern University
CollaboratorOTHER
University of New Mexico
CollaboratorOTHER
University of California, Irvine
CollaboratorOTHER
University of South Florida
CollaboratorOTHER
Emory University
CollaboratorOTHER
University of Alabama at Birmingham
CollaboratorOTHER
Johns Hopkins University
CollaboratorOTHER
Women and Infants Hospital of Rhode Island
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Provider inclusion criteria consists of FPMRS providers at study sites seeing new patients with symptoms of pelvic organ prolapse. Patient inclusion criteria consists of new patients 18 years or older with symptoms of pelvic organ prolapse.

Exclusion criteria

* Provider

Design outcomes

Primary

MeasureTime frame
Compare Decisional Conflict Scale scores measuring prolapse treatment-related decisional conflict reported by URMs to non-URMs after new patient consultations with FPMRS providers.immediately on enrollment.

Secondary

MeasureTime frameDescription
Identify variables correlated with discrepancies between patient-perceived and provider-perceived goals and treatment optionsimmediately on enrollment.Chart review of patient's medical history, exam findings, self-reported demographic variables to investigate if they are correlated with differences in self-reported patient goals and perception of treatment options offered (this is not a named questionnaire, this is a questionnaire developed for the study).
Explore variations in first-line treatments offered and/or selected for pelvic organ prolapse when stratified by race, ethnicity, and socioeconomic status.immediately on enrollment.Chart review of patient's medical history, exam findings, self-reported demographic background to investigate correlation with treatment patterns
Describe a possible correlation between race, ethnicity, and socioeconomic differences with scores on the Patient Autonomy Preferences Index and Patient Control Preferences Scaleimmediately on enrollment.Review of patient's self-reported demographic background information to assess to correlation with scores on above-mentioned scales.
Describe patient and clinical factors associated with increased scores on the Decisional Conflict Scaleimmediately on enrollment.perform chart review of patient's medical history, self-reported demographic variables, exam findings, symptom scores on the Pelvic Floor Distress Inventory and Decisional Conflict Scale scores
Investigate the relationship between Decisional Conflict Scale scores, Patient Satisfaction with Decision Making scores, and decisional instability 1 year after a new-patient visit.1 yearReview of patient's self-reported demographic background information to assess to correlation with scores on above-mentioned scales.
Investigate a correlation between Decisional Conflict Scale scores and zip-codeimmediately on enrollment.Review of whether distance driven to a hospital and/or living in a food desert is correlated with a higher Decisional Conflict Scale score.
Describe the association between race, ethnicity, and socioeconomic differences and scores on the Patient Satisfaction with Decision Scaleimmediately on enrollment.Review of patient's self-reported demographic background information to assess to correlation with scores on above-mentioned scale.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026